Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for ductal carcinomas in situ
Most Correlated Studies
- Response to neoadjuvant chemo (5-FU, epirubicin, cyclophosphamide) and resection in breast cancer
- Whole tissue breast cancer disease free survival (DFS) profiles after tamoxifen monotherapy
- Microdissected breast cancer disease free survival (DFS) profiles after tamoxifen monotherapy
- Breast tissues- early neoplasia or invasive ductal carcinoma (DC) or DC in situ compared with normal
- Ductal carcinoma in situ, invasive ductal carcinoma, and adjacent normal stromal cells
Most Relevant Literature
- Ductal Carcinoma In Situ.
- The role of endocrine treatment on the risk of developing an ipsilateral invasive breast cancer in h…
- Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost?
- Shifting paradigms for the treatment of ductal carcinoma in situ: Less is more.
- Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost? - Authors' …
Most Relevant Clinical Trials
- Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)
- Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ
- Effects of Diet and Exercise on Ductal Carcinoma in Situ
- Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)
- Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ
